Reported its financial results for the 2019 fourth quarter and fiscal year. First quarterly positive adjusted EBITDA of $0.2M in Q4 2019. 27% increase in Q4 2019 net cannabis revenue over the previous quarter. 1,748% increase in FY 2019 net cannabis revenue over the previous year. Gross margin on cannabis net revenue of 80% in Q4 2019. Q4 2019 SG&A expenses of $4.3 million, a decrease of 11% over previous quarter. $41.2M cash and cash equivalents at December 31, 2019. Aleafia Health Inc. shares T.ALEF are trading down $0.115 at $0.35.